Novartis Ag ADR (NVS)
$92.39
0.20 (0.22%)
NVS Stock Quote Delayed 30 Minutes
Louis Navellier's Top 6 Stocks for 2021
He found Apple at $1.49… Intel at $3.60... Amazon at $46. Now, investing legend Louis Navellier is revealing his Top 6 Stocks for 2021 — FREE!
Download His Free Report Here:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:
Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
-
Market Cap
-
PE Ratio
-
EPS
-
Volume (Avg. Vol.)
1.39M
Day's Range
92.30 - 92.92
52-Week Range
77.04 - 98.52
Dividend & Yield
2.98 (3.22%)
NVS Stock Predictions, Articles, and Novartis Ag ADR News
NLSP Stock: The Big Deal News That Has NLS Pharma Rocketing Nearly 100% Today
NLS Pharma (NLSP) stock is taking off on Friday after announcing an exclusive license agreement with Novartis (NVS) for mazindol data.
Why Novartis’ Absence From the Covid-19 Vaccine Race Is a Benefit
Although it’s one of the major pharmaceuticals, Novartis didn’t directly jump into the vaccine race. That might have been the best move for Novartis stock.
This Company is the Landlord of Life Sciences
Alexandria Real Estate Equities is the largest landlord in the US for laboratories and related offices.
This Stock Points to the Massive China Biotech Trend
There is ridiculously big upside potential for Chinese biotech stocks in the next decade. The spread of the pandemic has only strengthened the case.
Stock Market Today: Merger Monday; Tesla’s Cybertruck Pre-Orders
Tesla hit 200,000 pre-orders and there was a bevy of M&A to report. Here's what happened in the stock market today.
The Medicines Company News: MDCO Stock Rockets 22% on Novartis Deal
The Medicines Company (MDCO) news for Monday about a $9.70 billion deal with Novartis (NVS) has MDCO stock heading higher.
3 Biotech Stocks That Show The Good, The Bad and the Ugly Side of This Sector
When rumors start buzzing that the government may be about to intervene, then biotech stocks often get slammed...some fairly, and some not (as we’ll see).
10 Smart Dividend Stocks for the Rest of the Year
Ford, Verizon and AbbVie are just a trio of the top dividend stocks to buy for the remainder of 2019, particularly if the broad market hits turbulence.
New Sanofi CEO 2019: 8 Things to Know About Paul Hudson
There's a new Sanofi CEO preparing to join the company with current CEO Olivier Brandicourt retiring at the end of August.
Continued Smart M&A Moves Will Help Canopy Stock Break Out
Of course, the medical opportunity is massive, but Tilray competitor, Canopy Growth (NYSE:CGC), has been aggressively pursuing a multi-pronged approach that inherently diversifies the future revenue streams. CGC’s vision for THC as an ingredient in an array of consumer products separates them from an increasingly crowded industry.
4 Top Stock Trades for Tuesday: ROKU, ADSK, SPLK, NVS
Roku, Autodesk, Splunk and Novartis are our top stock trades on Friday. Going into the long weekend, see why we picked them for next week.
How and Why Tilray Stock Is a Buy Here
Following a long, steep correction and on the heels of earnings, there’s less to fear in stepping into a contrarian position in Tilray stock.
